CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
46.07
-1.19 (-2.52%)
Nov 21, 2024, 11:24 AM EST - Market open
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $3.93 billion as of November 21, 2024. Its market cap has decreased by -4.02% in one year.
Market Cap
3.93B
Enterprise Value
2.33B
1-Year Change
-4.02%
Ranking
Category
Stock Price
$46.07
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.93B, an increase of 602.06%. That is a compound annual growth rate of 27.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 4.01B | -19.37% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 4.43B |
| TG Therapeutics | 4.25B |
| BridgeBio Pharma | 4.22B |
| ICU Medical | 4.16B |
| Ultragenyx Pharmaceutical | 4.04B |
| Prestige Consumer Healthcare | 4.03B |
| Oscar Health | 3.95B |
| Sotera Health Company | 3.93B |